As with other types of cancer, mechanisms implicated in gliomagenesis and glioma progression are regulated by multiple parallel pathways, thus other metalloproteinases, cell receptors or signaling molecules could very well act concurrently with MMP9 in promoting GBM invasiveness. This evidence concerns the gene MMP9 and central nervous system cancer.